Warner Bros. Discovery, Inc.
Quinazoline compound for EGFR inhibition
Last updated:
Abstract:
Disclosed is a novel quinazoline compound. Specifically, disclosed are a compound represented by the formula (I) and a pharmacologically acceptable salt. ##STR00001##
Status:
Grant
Type:
Utility
Filling date:
29 Dec 2017
Issue date:
22 Jun 2021